KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for National Health Investors (NHI) over the last 17 years, with Q3 2025 value amounting to $47.4 million.

  • National Health Investors' Shares Outstanding (Weighted Average) rose 910.22% to $47.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.4 million, marking a year-over-year increase of 910.22%. This contributed to the annual value of $43.8 million for FY2024, which is 105.09% up from last year.
  • As of Q3 2025, National Health Investors' Shares Outstanding (Weighted Average) stood at $47.4 million, which was up 910.22% from $46.7 million recorded in Q2 2025.
  • Over the past 5 years, National Health Investors' Shares Outstanding (Weighted Average) peaked at $47.4 million during Q3 2025, and registered a low of $43.4 million during Q1 2023.
  • For the 5-year period, National Health Investors' Shares Outstanding (Weighted Average) averaged around $44.8 million, with its median value being $45.2 million (2022).
  • In the last 5 years, National Health Investors' Shares Outstanding (Weighted Average) plummeted by 536.95% in 2023 and then surged by 910.22% in 2025.
  • Over the past 5 years, National Health Investors' Shares Outstanding (Weighted Average) (Quarter) stood at $45.7 million in 2021, then dropped by 2.06% to $44.8 million in 2022, then decreased by 3.1% to $43.4 million in 2023, then grew by 1.05% to $43.8 million in 2024, then increased by 8.18% to $47.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $47.4 million for Q3 2025, versus $46.7 million for Q2 2025 and $45.7 million for Q1 2025.